Alpha 2.0
Login Register
» Articles » PMID: 20805313

Do Gliadin and Tissue Transglutaminase Mediate PPAR Downregulation in Intestinal Cells of Patients with Coeliac Disease?

Overview
Journal Gut
Specialty Gastroenterology
Date 2010 Sep 1
PMID 20805313
Citations 7
Authors
V De Re
M P Simula
A Notarpietro
V Canzonieri
R Cannizzaro
G Toffoli
Affiliations
Soon will be listed here.
Citing Articles

The critical role of dysregulation of antioxidant activity and carbohydrate metabolism in celiac disease.

Khalkhal E, Rezaei-Tavirani M, Razzaghi M, Rezaei-Tavirani S, Zali H, Rostamii-Nejad M Gastroenterol Hepatol Bed Bench. 2019; 12(4):340-347.

PMID: 31749923 PMC: 6820838.

New Insights into the Pathogenesis of Celiac Disease.

De Re V, Magris R, Cannizzaro R Front Med (Lausanne). 2017; 4:137.

PMID: 28913337 PMC: 5583152. DOI: 10.3389/fmed.2017.00137.

Peroxisome proliferator-activated receptor-γ and thymic stromal lymphopoietin are involved in the pathophysiology of childhood coeliac disease.

Sziksz E, Molnar K, Lippai R, Pap D, Onody A, Veres-Szekely A Virchows Arch. 2014; 465(4):385-93.

PMID: 25187315 DOI: 10.1007/s00428-014-1650-2.

Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.

Ferretti G, Bacchetti T, Masciangelo S, Saturni L Nutrients. 2012; 4(4):243-57.

PMID: 22606367 PMC: 3347005. DOI: 10.3390/nu4040243.

Role of transglutaminase 2 in celiac disease pathogenesis.

Klock C, Diraimondo T, Khosla C Semin Immunopathol. 2012; 34(4):513-22.

PMID: 22437759 PMC: 3712867. DOI: 10.1007/s00281-012-0305-0.